Showing results (311-320 of 383) with videos related to

Sort By:
Pageof 39
American Journal of Respiratory and Critical Care Medicine|June 11, 2005
Reinfection and mixed infection cause changing Mycobacterium tuberculosis drug-resistance patternsAnnelies van Rie, Thomas C Victor, Madalene Richardson, et al.
Frontiers in Immunology|July 5, 2017
Changes in Host Immune-Endocrine Relationships during Tuberculosis Treatment in Patients with Cured and Failed Treatment OutcomesLéanie Kleynhans, Sheena Ruzive, Lizaan Ehlers, et al.
Journal of Clinical Microbiology|May 4, 2007
Evidence that the spread of Mycobacterium tuberculosis strains with the Beijing genotype is human population dependentM Hanekom, G D van der Spuy, N C Gey van Pittius, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2012
Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testingE M Streicher, I Bergval, K Dheda, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 14, 2004
Identification of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi, KenyaW A Githui, A M Jordaan, E S Juma, et al.
Veterinary Immunology and Immunopathology|January 1, 2019
Parallel testing increases detection of Mycobacterium bovis-infected African buffaloes (Syncerus caffer)Netanya Bernitz, Wynand J Goosen, Charlene Clarke, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 17, 2009
Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strainR Johnson, R M Warren, G D van der Spuy, et al.
Preventive Veterinary Medicine|July 18, 2019
Parallel measurement of IFN-γ and IP-10 in QuantiFERON®-TB Gold (QFT) plasma improves the detection of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)Netanya Bernitz, Tanya J Kerr, Wynand J Goosen, et al.
BMC Medicine|April 9, 2016
Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacyIsobella Honeyborne, Timothy D McHugh, Iitu Kuittinen, et al.
Veterinary Immunology and Immunopathology|August 31, 2019
Impact of Mycobacterium bovis-induced pathology on interpretation of QuantiFERON®-TB Gold assay results in African buffaloes (Syncerus caffer)Netanya Bernitz, Tanya J Kerr, Wynand J Goosen, et al.
Pageof 39